The use of drug discrimination procedures to characterize hallucinogenic drug actions
Appel, J.B.; Cunningham, K.A.
Psychopharmacology Bulletin 22(3): 959-967
1986
ISSN/ISBN: 0048-5764 PMID: 3797596 Document Number: 279546
Document emailed within 1 workday
Related Documents
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75Haan, J. 1981: Drug dependence. a review of the narcotic and hallucinogenic effects of drugs Medizinische Monatsschrift für Pharmazeuten 4(5): 129-137
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Bridger, W.H. 1975: Good trip or bad trip: the roles of tolerance and stress in hallucinogenic drug action Advances in Biochemical Psychopharmacology 13: 287-298
Krieglstein, J. 1997: Mechanisms of neuroprotective drug actions Clinical Neuroscience 4(4): 184-193
Saano, V. 1987: GABA-benzodiazepine receptor complex and drug actions Medical Biology 65(2-3): 167-173
Matsuda, T. 1993: Antithrombotic drug (thrombolytic drug, anticoagulant, antiplatelet drug) Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 179-185
Schauf, C.L.; Davis, F.A.; Kesler, R.L. 1975: Actions of the antidepressant drug imipramine on the voltage-clamped Myxicola giant axon Journal of Pharmacology and Experimental Therapeutics 193(2): 669-675
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737
Barré, J. 2004: Drug registration file prerequisites for European procedures Annales Pharmaceutiques Francaises 62(3): 207-213
Fox, T.C.; Robinson, C.L. 1990: Establishing procedures to implement drug therapy rules Provider 16(10): 65-66
Bach, K.F.; Jørgensen, A. 2013: Simplification of procedures for clinical drug trials in the EU is coming up Ugeskrift for Laeger 175(46): 2778-2781
Koch, K.E. 1990: Use of standardized screening procedures to identify adverse drug reactions American Journal of Hospital Pharmacy 47(6): 1314-1320
Yanagihara, Y.; Abe, T.; Kuroda, T.; Shida, T. 1988: Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 5th communication: effects on immunological reactions in mice and humans Arzneimittel-Forschung 38(1): 88-92
Sankar, D.V.; Kumbar, M. 1974: Quantum chemical studies on drug actions. IV. Correlation of substituent structures and anti-serotonin activity in lysergamide series Research Communications in Chemical Pathology and Pharmacology 7(2): 259-274
Jones, D.B.; Morgan, D.J.; Mihaly, G.W.; Webster, L.K.; Smallwood, R.A. 1984: Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding Journal of Pharmacology and Experimental Therapeutics 229(2): 522-526
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Garfein, R.S.; Swartzendruber, A.; Ouellet, L.J.; Kapadia, F.; Hudson, S.M.; Thiede, H.; Strathdee, S.A.; Williams, I.T.; Bailey, S.L.; Hagan, H.; Golub, E.T.; Kerndt, P.; Hanson, D.L.; Latka, M.H. 2007: Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT) Drug and Alcohol Dependence 91(Suppl 1): S4-17
Matsubara, M.; Suzuki, S.; Miura, K.; Terashima, M.; Hatsuda, S.; Sugita, S.; Murakami, H.; Nakazawa, K.; Ohara, M. 1997: A study of the effects of antidepressants on the GABAA receptor and its complex based on the drug actions on the power-spectral changes of rat hippocampal EEG induced by GABA antagonists and inverse agonists Nihon Shinkei Seishin Yakurigaku Zasshi 17(2): 75-83